Search

Your search keyword '"Huang AS"' showing total 14,431 results

Search Constraints

Start Over You searched for: Author "Huang AS" Remove constraint Author: "Huang AS" Journal blood Remove constraint Journal: blood
14,431 results on '"Huang AS"'

Search Results

1. A predictive model for therapy failure in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitor therapy

3. Phase 1 study of CAR-37 T cells in patients with relapsed or refractory CD37+ lymphoid malignancies

4. An LGR6 frameshift variant abrogates receptor expression on select leukocyte subsets and is associated with viral infections

8. Venetoclax dose escalation rapidly activates a BAFF/BCL-2 survival axis in chronic lymphocytic leukemia

10. Genome-wide transcription factor–binding maps reveal cell-specific changes in the regulatory architecture of human HSPCs

12. Disruption of dNTP homeostasis by ribonucleotide reductase hyperactivation overcomes AML differentiation blockade

15. The non-cell-autonomous function of ID1 promotes AML progression via ANGPTL7 from the microenvironment

17. Genomic landscape of Down syndrome–associated acute lymphoblastic leukemia

18. Genetic disruption of N-RasG12D palmitoylation perturbs hematopoiesis and prevents myeloid transformation in mice.

19. Pluripotent stem cell–derived NK cells with high-affinity noncleavable CD16a mediate improved antitumor activity

22. Polatuzumab vedotin in previously untreated DLBCL: an Asia subpopulation analysis from the phase 3 POLARIX trial

24. Venetoclax and idasanutlin in relapsed/refractory AML: a nonrandomized, open-label phase 1b trial

25. Acquired mutations in BAX confer resistance to BH3-mimetic therapy in acute myeloid leukemia

26. PRL2 phosphatase enhances oncogenic FLT3 signaling via dephosphorylation of the E3 ubiquitin ligase CBL at tyrosine 371

28. Single-cell multiomics reveal the scale of multilayered adaptations enabling CLL relapse during venetoclax therapy

37. Genome-wide CRISPR screen identifies CDK6 as a therapeutic target in adult T-cell leukemia/lymphoma

38. Clonal hematopoiesis, myeloid disorders and BAX-mutated myelopoiesis in patients receiving venetoclax for CLL

41. EBV-driven lymphoid neoplasms associated with pediatric ALL maintenance therapy

42. Single-cell landscape of idiopathic multicentric Castleman disease in identical twins

47. Rare and low-frequency variants and their association with plasma levels of fibrinogen, FVII, FVIII, and vWF

49. Phase 1 study of the selective BTK inhibitor zanubrutinib in B-cell malignancies and safety and efficacy evaluation in CLL

Catalog

Books, media, physical & digital resources